Magenta Therapeutics

Magenta Therapeutics
Last activity: 14.05.2021
Magenta Therapeutics is a clinical-stage biotech developing therapeutics to curative power of stem cell transplants to more patients
Total raised: $150.5M
Founded date: 2016

Investors 3

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
09.04.2018Series C$
02.05.2017Series B$50M-citybizlis...
16.11.2016Series A$48.5M-citybizlis...

Mentions in press and media 24

14.05.2021MAGENTA THERAPEUTICS, INC. Magenta Therapeutics : Announces...Magenta Therapeutics Announces $86.4 Million Common Stock Investment from Multiple Investors CAMBRI...marketscre...
12.05.2021MAGENTA THERAPEUTICS, INC. Magenta Therapeutics : Announces...Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel m...marketscre...
01.12.2020Slone Partners Places Kevin B. Johnson as Senior Vice Presid...“Dr. Johnson is an experienced industry leader with extensive knowledge of the current regulatory
13.09.2020Акции, стартапы, недвижимость: куда инвестируют Гарвард, Йел...Активы шести университетских фондов — около $178 млрд. Среди их инвестиций компании вроде Google,
06.05.2020AVROBIO and Magenta Therapeutics Announce Collaboration to E...Collaboration focuses on advancing innovation with antibody-drug conjugate (ADC)-based conditioning ...svhealthin...
10.04.2018Term Sheet — Tuesday, April 10BIKE SHARING WARS The bike-sharing war is roaring in the United States following its explosive
09.04.2018Magenta Therapeutics Secures $52M in Series C FinancingMagenta Therapeutics, a Cambridge, MA-based biotechnology company developing novel medicines,
09.04.2018Magenta Therapeutics Secures $52M in Series C CAMBRIDGE, MA, Biotechnology company developing novel medicines to bring the curative power of bon...vcnewsdail...
09.04.2018Magenta Therapeutics Secures $52 Million in Series C Financi...CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, a biotechnology company developing novel me...citybizlis...
21.02.2018Top Pfiz­er re­search ex­ec John Davis joins mi­gra­tion to ...John Davis Sue Dil­lon isn’t the on­ly Big Phar­ma R&D ex­ec to make news this week af­ter mak­
Show more